Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Barbituric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.32 |
| ▸ | ITGAV | P06756 | 1/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Barbituric Acid SCHEMBL691401 | 0.93 | SRC (0.33) | — | |
| Barbituric Acid SCHEMBL20522064 | 0.81 | SRC (0.32) | ITGB3ITGB1ITGAVITGA4 | |
| Barbituric Acid SCHEMBL27465421 | 0.64 | ITGB3 (0.44) | ITGB3ITGB1ITGAVITGA4HPGD | |
| SCHEMBL24171396 | 0.62 | KDM4E (0.33) | HPGD | |
| Thiobarbituric SCHEMBL7714190 | 0.62 | ALDH1A1 (0.42) | HPGD | |
| Acetic Acid SCHEMBL6517807 | 0.62 | FFAR3 (0.64) | — | |
| Acetic Acid SCHEMBL6113 | 0.62 | — | — | |
| Acetic Acid SCHEMBL6290880 | 0.62 | FFAR3 (0.64) | — | |
| Acetic Acid SCHEMBL10590923 | 0.62 | FFAR3 (0.64) | — | |
| Acetic Acid SCHEMBL27432872 | 0.62 | FFAR3 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020193404-A1 | Use of bicyclic heterocycles for the treatment and prevention of arterial thrombotic disease | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193404-A1 | Use of bicyclic heterocycles for the treatment and prevention of arterial thrombotic disease | TBXA2R, SERPINC1, TBXAS1 | ITGB3 1244/4885ITGB1 1831/4885ITGAV 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.